Related JUNOGene Therapy Stocks Take Beating On Bad News For CelladonCAR-T Therapy Stocks Hit Hard Following AACR DataThe Real Value In MabVax May Be Partnerships Rather Than Pipeline(Seeking Alpha)While short interest in most of the leading biotechs and emerging pharmaceuticals shrank between the March 31 and April 15 settlement dates, three stocks bucked that trend.Juno Therapeutics Inc (NASDAQ: JUNO) and […]
PrintSubscribeinvestingDid you miss the stock market rally? You’re not aloneBy Claes Bell, CFA • Bankrate.comIt’s often said that a rising tide lifts all boats, but a rising tide isn’t much help if you don’t have a boat. In the midst of a six-year market rally, more than half of Americans don’t own any stock investments at all, potentially missing out […]
Long story short… yes, there appears to be a relationship between economic growth and stock market performance within the U.S. (and developed world), but that relationship holds only over longer periods of time and does not hold for all countries (less developed countries often “divert” growth to the political elite). Also, for those interested in the relationship between long-term economic […]
View All3 Best-of-Breed Small Caps: Biotech Stocks to BuyNo one can deny the performance of biotech and biopharma stocks over the last six months as they have outperformed the entire market. The sector has done so well that it has brought back that dreaded word that everyone has feared in this sector since 2000: “bubble.”Source: ©iStock.com/AlexRathsHowever, it’s shortsighted to look at […]
SAN FRANCISCO (MarketWatch)—Investors looking for early warnings signs of a shift in U.S. market sentiment would do well to watch tech and biotech stocks.That is because a selloff in those sectors is likely to signal that investors’ confidence in U.S. equities is deteriorating, according to Bank of America Merrill Lynch analyst Michael Hartnett“U.S. bear view requires [a] tech-wreck,” he writes […]
In fact, biotech stocks have been so strong that “you could see these stocks off another 10 percent from here, and still be in an uptrend,” Johnson said. “We’d be buying these names on the pullback.”The fundamentals also remain supportive of biotech, says David Seaburg, head of equity sales trading with Cowen & Co.”From a valuation perspective, this is not […]
In fact, biotech stocks have been so strong that “you could see these stocks off another 10 percent from here, and still be in an uptrend,” Johnson said. “We’d be buying these names on the pullback.”The fundamentals also remain supportive of biotech, says David Seaburg, head of equity sales trading with Cowen & Co.”From a valuation perspective, this is not […]
Biotech bubble may just be an optical illusion
By iCELL News on March 27, 2015 · Sector
SAN FRANCISCO (MarketWatch)—The stellar performance of biotechnology stocks in the past few years has predictably sparked fears of an impending crash. But for all the talk of a bubble, biotechs are far from being overbought, according to analysts at Credit Suisse.“There are optics suggesting that […]
Wikimedia CommonsThere is probably a bubble in biotech stocks. In a big note on published on Friday, analysts at Credit Suisse ask if we’re in a biotech bubble, and answer that no, it’s not a bubble, merely a “new era” for biotech stocks. Which is exactly what it sounds like when something is a bubble. Credit Suisse hinges its argument on what it […]
View gallery.(Wikimedia Commons)There is probably a bubble in biotech stocks.
In a big note on published on Friday, analysts at Credit Suisse ask if we’re in a biotech bubble, and answer that no, it’s not a bubble, merely a “new era” for biotech stocks. Which is exactly what it sounds like when something is a bubble. Credit Suisse hinges its argument on what […]
